Advertisement Agendia names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Agendia names new CFO

Agendia, a developer of molecular cancer diagnostics, has appointed Kurt Schmidt as its new CFO. Mr Schmidt succeeds former CFO, John Die, who has been an exemplary guide for Agendia during his tenure.

Most recently, Mr Schmidt was a principal at a consulting firm he founded in 2002, providing high-level interim financial management and M&A services.

Prior to that, Mr Schmidt served as operations director at B2eMarkets, a supply chain technology company, and director of finance and operations at LA Gear Europe. Mr Schmidt started his career at Cardinal Health in corporate finance.

Mr Schmidt said: “I am delighted to join Agendia during this exciting time and help prepare the company for our next financing round. I look forward to our first investor meetings next week during the JP Morgan Healthcare Conference in San Francisco.”